Meeting Prometheus: The Mechanism of MSC-Based Therapies; Cell Replacement or “Pretended Bystander Effects”?

References (1)

1. Chen B, Zhang F, Li QY, Gong A, Lan Q: Protective effect of Ad-VEGF-Bone mesenchymal stem cells on cerebral infarction. Turk Neurosurg 26:8-15, 2016 2. Chopp M, Li Y: Treatment of neural injury with marrow stromal cells. Lancet Neurol 1:92-100, 2002 3. Dong HJ, Shang CZ, Li G, Niu Q, Luo YC, Yang Y, Meng HP, Yin HJ, Zhang HX, Zhao ML, Lin L: The Distribution of transplanted umbilical cord mesenchymal stem cells in large blood vessel of rats with traumatic brain injury. J Craniofac Surg 28:1615–1619,2017 4. Kurozumi K, Nakamura K, Tamiya T, Kawano Y, Ishii K, Kobune M, Hirai S, Uchida H, Sasaki K, Ito Y, Kato K, Honmou O, Houkin K, Date I, Hamada H: Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model. Mol Ther 11:96- 104, 2005 5. Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I, Lanino E, Sundberg B, Bernardo ME, Remberger M, Dini G, Egeler RM, Bacigalupo A, Fibbe W, Ringden O, Developmental Committee of the European Group for B, Marrow T: Mesenchymal stem cells for treatment of steroidresistant, severe, acute graft-versus-host disease: A phase II study. Lancet 371:1579-1586, 2008 6. Li G, Yang Y, Dong HJ, Lin L: The research progress of mesenchymal stem cells in the treatment of traumatic brain injury. Turk Neurosurg 2017 Jul 16 (Epub ahead of print) 7. Phinney DG, Pittenger MF: Concise review: MSC-derived exosomes for cell-free therapy. Stem Cells 35:851–858, 2017 8. Zhang B, Wu X, Zhang X, Sun Y, Yan Y, Shi H, Zhu Y, Wu L, Pan Z, Zhu W, Qian H, Xu W: Human umbilical cord mesenchymal stem cell exosomes enhance angiogenesis through the Wnt4/ beta-catenin pathway. Stem Cells Transl Med 4:513-522, 2015